Immunohistochemistry (IHC) Market Is Projected To Witness Growth Based On Increasing Occurrence Of CancerTill 2025:Grand View Research,inc.
The global immunohistochemistry (IHC) market is estimated to
reach a value of USD 3.1 billion by 2025, according to a new report by Grand
View Research, Inc. The rising prevalence of cancer and increasing healthcare
expenses driven by expanding aging population base are recognized to be the
most influential factors driving the growth of the immunohistochemistry market.
Furthermore, the rapid growth of biotech industry highlighted by increase in
growth and revenue coupled with increase in stock market capitalization will
nurture the growth.
Cancer has high morbidity and
mortality risk associated with them. The diagnosis of the disease is majorly
dependent on the stage of the disease at admission. This has led to the high
demand of immunohistochemistry products. IHC staining process is performed on
cancer tissues to reveal the presence of HER2 receptors and/or hormone
receptors on their surface. This information plays a vital role in planning the
treatment for the disease, creating a demand for immunohistochemistry products.
In addition, the rising popularity of targeted immunotherapy and biologic
therapy for anticancer drug development and the increasing approvals of the
same by the FDA to treat specific types of cancer are expected to benefit the
growth in the long run.
Other important factors driving
growth include the alarming rise in healthcare spending and the shift in focus
on value-based healthcare solutions. In 2015, the U.S. healthcare spending
witnessed an increase of 5.8% to reach a value of USD 3.2 trillion. To curb the
issue and establish a more value-based healthcare delivery, hospitals and care
facilities are adopting a more specific and targeted therapy for better
outcomes.
Browse full research report on Immunohistochemistry (IHC)
Market: http://www.grandviewresearch.com/industry-analysis/immunohistochemistry-ihc-market
Further key findings from
the study suggest:
- North America registered the largest growth rate in
the immunohistochemistry market in 2016
- The APAC region is expected to witness the fastest
growth owing to increasing healthcare expenses driven by expanding aging
population offering significant growth opportunities for players
- The hospitals and diagnostic laboratories segment
accounted for the largest share of the immunohistochemistry market, by
end-use due to the growing application of immunohistochemistry products
for diagnostic procedures
- The antibody segment accounted for the largest share
of immunohistochemistry market due to the increase in approvals by
regulatory bodies for therapeutic antibody products
- Key players mapped in the report include Abcam plc,
Agilent Technologies, BioSB, Cell Signaling Technology, Inc., Danaher
Corporation, F. Hoffmann-La Roche Ltd, Merck Millipore, PerkinElmer Inc.,
and Thermo Fisher Scientific Inc.
Grand View Research has segmented the immunohistochemistry
market on the basis of product, application, and end-use:
Product Outlook (Revenue, USD Million; 2014 - 2025)
- Antibodies
- Primary
antibodies
- Secondary
antibodies
- Equipment
- Slide
staining systems
- Tissue
microarrays
- Tissue
processing systems
- Slide
scanners
- Others
- Reagents
- Histological
stains
- Blocking
sera and reagents
- Chromogenic
substrates
- Fixation
reagents
- Stabilizers
- Organic
solvents
- Proteolytic
enzymes
- Diluents
- Kits
Application Outlook (Revenue, USD Million; 2014 -
2025)
- Diagnostics
- Cancer
- Infectious
diseases
- Cardiovascular
diseases
- Autoimmune
diseases
- Diabetes
mellitus
- Nephrological
diseases
- Drug
Testing
End- Use Outlook (Revenue, USD Million; 2014 - 2025)
- Hospitals
and diagnostic laboratories
- Research
institutes
- Others
Regional Outlook (Revenue, USD Million; 2014 - 2025)
- North
America
- U.S.
- Canada
- Europe
- Germany
- UK
- Asia
Pacific
- Japan
- China
- India
- Latin
America
- Brazil
- Mexico
- MEA
- South
Africa
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides
syndicated research reports, customized research reports, and consulting services.
To help clients make informed business decisions, we offer market intelligence
studies ensuring relevant and fact-based research across a range of industries,
from technology to chemicals, materials and healthcare.
Comments
Post a Comment